Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Primary Completion Date

October 31, 2002

Conditions
Endometrial Cancer
Interventions
DRUG

paclitaxel

Trial Locations (8)

3049

Hospitais da Universidade de Coimbra (HUC), Coimbra

10128

Ospedale Mauriziano Umberto I, Torino

27058

Ospedale Civile, Voghera (PV)

28040

Hospital Universitasrio San Carlos, Madrid

A-1090

Allgemeines Krankenhaus der Stadt Wien, Vienna

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

NE9 6SX

Queen Elizabeth Hospital, Gateshead

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00022620 - Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | Biotech Hunter | Biotech Hunter